Broadcom's 2028 Projection Makes the Stock a Screaming Buy

Broadcom CEO Hock Tan said the company has secured supply to approximately double AI semiconductor revenue to $115 billion in fiscal 2027 and double it again to $230 billion in fiscal 2028, supported by custom-chip engagements with hyperscalers including Alphabet, Meta, OpenAI and Anthropic. The article argues that these projections are not reflected in Broadcom's valuation, citing a forward P/E below 18x and potential for substantial earnings-driven upside. The outlook depends on Broadcom executing on supply expansion and sustained hyperscaler demand for custom AI accelerators.

Analysis

The investable question is not whether AI revenue can compound, but whether AVGO can convert multiyear capacity reservations into high-margin, non-cancelable revenue without ceding economics to hyperscale customers. Custom ASICs can expand AVGO's content per customer, yet they also increase buyer concentration and create a lumpy recognition profile: a delay at one large program can matter more than broad-based enterprise AI demand. The market is likely to require evidence of backlog quality, cancellation protections, and gross-margin durability before assigning a sustained premium multiple to distant revenue targets.

The second-order competitive effect is mixed for NVDA. ASIC adoption at GOOG and META is a negative read-through for the share of training/inference workloads addressable by merchant GPUs, but it does not automatically reduce total accelerator spending; it can instead enlarge the overall AI capex envelope. TSM is a cleaner volume beneficiary if leading-edge wafer and advanced-packaging demand remains constrained, while MRVL is the more direct relative loser if AVGO's scale and customer relationships increasingly win custom-silicon programs.

Near term, AVGO is vulnerable to a "show me" reaction if the next two earnings reports do not translate long-range projections into rising near-term AI run-rate, supply commitments, and segment margin. Over 6-18 months, the upside case is material if the company demonstrates that custom silicon is additive rather than substitutive to networking and software cash flow. The key falsifier is any reduction in hyperscaler capex plans, a pushout in secured supply, or AI semiconductor growth that decelerates materially before the 2027 ramp; those outcomes would expose the stock to both estimate cuts and multiple compression.

Key Decisions for Investors

• Accumulate AVGO only on post-results confirmation: initiate a 1.5-2.0% long if the next earnings release shows sequential AI revenue acceleration and management reiterates both supply availability and margin trajectory. Target a 12-18 month rerating on de-risked earnings power; exit if AI guidance is cut or a major customer program slips.
• Express the ASIC-share-gain thesis as long AVGO / short MRVL in equal dollar amounts over the next 3-6 months. This isolates custom-silicon execution and customer-access advantages from broad semiconductor beta; stop the spread if MRVL discloses a comparable hyperscaler design win or AVGO indicates concentration-driven pricing pressure.
• Maintain NVDA exposure rather than treating AVGO as a wholesale substitute, but hedge incremental AVGO longs with a modest SMH or SOXX downside hedge into earnings. The principal 1-3 month risk is that AI capex remains strong while AVGO-specific conversion timing disappoints.
• Set an alert around hyperscaler capex guidance from GOOG and META. A coordinated upward revision supports AVGO's 2027 supply ramp and TSM demand; a capex pause or slower deployment commentary is the earliest practical warning that long-dated ASIC estimates are too high.